Erin Fuse Brown

Erin Fuse Brown, a professor at the Brown University School of Public Health, discusses controversial partnerships between pharmaceutical firms and telehealth services. She reveals how these alliances can improve access to medications but may lead to inappropriate prescribing and increased healthcare costs. The conversation highlights the role of targeted advertising and the challenges posed by federal regulations. Brown emphasizes the need for greater transparency and stricter guidelines to protect patients in this rapidly evolving landscape.

In this engaging discussion, Erin Fuse Brown, a professor at Brown University School of Public Health, delves into the complex topic of healthcare corporatization. She outlines how profit-driven motives are reshaping healthcare priorities, often at the expense of patient care and worker support. The conversation highlights the rising influence of private equity and corporate consolidation, which escalate costs and diminish service quality. Erin also discusses the toll on physician-patient relationships and offers insights on restructuring the system to better serve community needs.

Erin Fuse Brown, a health services expert at Brown University, discusses pivotal recent Supreme Court rulings that challenge long-standing legal doctrines impacting healthcare regulation. She explores the uncertain future of administrative law and the potential consequences for health agencies like HHS and FDA. With increased scrutiny of regulatory interpretations, agencies may proceed with caution, complicating the establishment of new health policies. The conversation emphasizes the need for clearer Congressional authority to navigate these challenges effectively.